BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1107505)

  • 1. Ovarian hyperthecosis in the adolescent patient.
    Wentz AC; Gutai JP; Jones GS; Migeon CJ
    J Pediatr; 1976 Mar; 88(3):488-93. PubMed ID: 1107505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial hyperthecosis: comparison of endocrinologic and histologic findings with polycystic ovarian disease.
    Judd HL; Scully RE; Herbst AL; Yen SS; Ingersol FM; Kliman B
    Am J Obstet Gynecol; 1973 Dec; 117(7):976-82. PubMed ID: 4759835
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
    Rittmaster RS; Thompson DL
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined dexamethasone and human chorionic gonadotropin in diagnosis of polycystic ovarian disease.
    Beck WW; McEvoy D; Wallach EE
    Obstet Gynecol; 1971 Feb; 37(2):211-7. PubMed ID: 5539356
    [No Abstract]   [Full Text] [Related]  

  • 5. Correlation of the effects of dexamethasone administration on urinary 17-ketosteroid and serum androgen levels in patients with hirsutism.
    Judd HL; McPherson RA; Rakoff JS; Yen SS
    Am J Obstet Gynecol; 1977 Jun; 128(4):408-17. PubMed ID: 141210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian 17-ketosteroid reductase deficiency as a possible cause of polycystic ovarian disease.
    Toscano V; Balducci R; Bianchi P; Mangiantini A; Sciarra F
    J Clin Endocrinol Metab; 1990 Aug; 71(2):288-92. PubMed ID: 2166066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic evaluation of hirsutism in women.
    Farber M; Millan VG; Turksoy RN; Mitchell GW
    Clin Obstet Gynecol; 1977 Mar; 20(1):1-9. PubMed ID: 837574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperthecosis syndrome. Clinical, endocrinologic and histologic findings.
    Karam K; Hajj S
    Acta Obstet Gynecol Scand; 1979; 58(1):73-9. PubMed ID: 419961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hirsutism, polycystic ovarian disease, and ovarian 17-ketosteroid reductase deficiency.
    Pang SY; Softness B; Sweeney WJ; New MI
    N Engl J Med; 1987 May; 316(21):1295-301. PubMed ID: 3472077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic evaluation of hirsutism in women by selective bilateral adrenal and ovarian venous catheterization.
    Farber M; Millan VG; Turksoy RN; Mitchell GW
    Fertil Steril; 1978 Sep; 30(3):283-8. PubMed ID: 710599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical findings and hormonal responses in patients with polycystic ovarian disease with normal versus elevated LH levels.
    Givens JR; Andersen RN; Umstot ES; Wiser WL
    Obstet Gynecol; 1976 Apr; 47(4):388-94. PubMed ID: 1256723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen and estrogen formation in women with ovarian hyperthecosis.
    Aiman J; Edman CD; Worley RJ; Vellios F; MacDonald PC
    Obstet Gynecol; 1978 Jan; 51(1):1-9. PubMed ID: 619322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperandrogenism. Tests that simplify evaluation.
    Hammond MG; Talbert LM; Groff TR
    Postgrad Med; 1986 Feb; 79(3):107-13. PubMed ID: 3003722
    [No Abstract]   [Full Text] [Related]  

  • 14. Diurnal change of serum androstenedione and testosterone and response to hCG and dexamethasone in women with polycystic ovaries, adrenal hyperandrogenism and unexplained hirsutism.
    Lisse K; Schürenkämper P; Friedrich W; Rutkowsky J
    Acta Endocrinol (Copenh); 1980 Feb; 93(2):216-22. PubMed ID: 7189630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of suppression and recovery of plasma FSH, LH, androstenedione and testosterone in polycystic ovarian disease using an oral contraceptive.
    Givens JR; Andersen RN; Wiser WL; Fish SA
    J Clin Endocrinol Metab; 1974 May; 38(5):727-35. PubMed ID: 4823918
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of virilizing adrenal tumors in hirsute women.
    Derksen J; Nagesser SK; Meinders AE; Haak HR; van de Velde CJ
    N Engl J Med; 1994 Oct; 331(15):968-73. PubMed ID: 8084355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the adrenal-ovarian contribution by short-term dexamethasone and ACTH tests in hyperandrogenized patients.
    Fulghesu AM; Lanzone A; Apa R; Fortini A; Caruso A; Mancuso S
    Gynecol Endocrinol; 1991 Mar; 5(1):37-48. PubMed ID: 1654730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remission of acanthosis nigricans associated with polycystic ovarian disease and a stromal luteoma.
    Givens JR; Kerber IJ; Wiser WL; Andersen RN; Coleman SA; Fish SA
    J Clin Endocrinol Metab; 1974 Mar; 38(3):347-55. PubMed ID: 4360917
    [No Abstract]   [Full Text] [Related]  

  • 19. Hirsutism and virilism in women.
    Kirschner MA
    Spec Top Endocrinol Metab; 1984; 6():55-93. PubMed ID: 6084314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated 24-hour luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovarian syndrome.
    Apter D; Bützow T; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1994 Jul; 79(1):119-25. PubMed ID: 8027216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.